COMMISSIONER OF INCOME TAX-1 CHANDIGARH vs. M/S DSM ANTI INFECTIVES INDIA LTD (NOW DSM SINOCHEM PHARMACEUTICALS INDIA PVT LTD)

Facts

The Revenue (Commissioner of Income Tax-I, Chandigarh) appealed an order dated August 8, 2013, passed by the Income Tax Appellate Tribunal (ITAT), Chandigarh Bench. The ITAT had accepted the assessee's (M/s DSM Anti Infectives India Ltd.) appeal, setting aside the Assessing Officer's (AO) order dated October 28, 2010. The AO had made additions concerning interest on advances, commission paid, and disallowance under Section 14A. The appeal challenges the ITAT's findings on several substantial questions of law. The amount in dispute for commission was Rs. 42,77,213/-. The AO disallowed Rs. 92.00 lacs on account of commissions and Rs. 12,40,501/- under Section 14A. The ITAT restored the commission issue to the AO for fresh examination and deleted the addition under Section 14A.

Held

The High Court held that the revenue's appeal was dismissed. Regarding questions 1 and 2, the revenue conceded that these were answered against them in a previous appeal (ITA No. 257 of 2009). For question 3 concerning commission, the Court found no error in the ITAT restoring the matter to the AO for fresh examination regarding the identity of recipients and the nature of transactions, stating the AO had made a summary disallowance without inquiry. The Court found no jurisdictional error or perversity in the Tribunal's discretion. For questions 4 and 5 concerning Section 14A, the Court upheld the ITAT's finding that the investment in M/s Hindustan Max-GB Ltd. was made for business expediency (to procure raw material) and that the AO had attempted to shift income under Section 14A after failing to include it under Section 36(1)(iii). The Court noted that the investment was old, the company was before BIFR, and no interest had been paid for over a decade. Therefore, the ITAT rightly deleted the addition under Section 14A. The Court answered all substantial questions of law against the revenue.

Key Issues

The Tribunal had to decide the following substantial questions of law: 1. Whether the Tribunal was right in relying on Section 36(1)(iii) in isolation, without considering that the assessee both borrowed and advanced money, from which interest income was receivable. 2. Whether the Tribunal was right in holding that advances to Hindustan Max G.B. were for commercial expediency, especially since they pertained to earlier years and no such transactions occurred in succeeding years. 3. Whether the Tribunal was right in granting relief of Rs. 42,77,213/- on commission paid on domestic sales, and in holding that the AO could not interfere with commission rates even if unreasonable, and that the assessee could not prove actual payment. 4. Whether the Tribunal was right in not appreciating that Section 14A is applicable irrespective of business expediency in investments. 5. Whether the Tribunal was right in holding Section 14A not applicable despite the assessee investing in shares from which dividend income would be exempt. Assessee's contentions: The assessee contended that commission was paid for sourcing raw materials. The investment in M/s Hindustan Max-GB Ltd. was for business expediency to procure raw materials. The ITAT restored the commission issue to the AO for fresh examination. The ITAT deleted the addition under Section 14A as the investment was made for business expediency. Revenue's contentions: The revenue argued that the ITAT erred in restoring the commission issue to the AO, as there was no contract or confirmation from recipients, and the AO should have determined the correctness, not just the quantum. Regarding Section 14A, the revenue contended that it applies irrespective of business expediency, as the assessee received interest and dividend income from investments in shares, which falls under Section 14A. The revenue relied on the fact that the assessee invested Rs. 5.00 crores in M/s HMGV, was allotted shares, and received interest and dividend.